Immucor NEO Iris - HSA Registration DE0504646
Access comprehensive regulatory information for Immucor NEO Iris in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0504646 and owned by Immucor Medizinische Diagnostik GmbH. The device was registered on June 30, 2020.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The NEO Iris is a microprocessor-controlled instrument designed to fully automate immunohematology in vitro diagnostic testing of human blood. The NEO Iris automates test processing, result interpretation, and data management functions. The NEO Iris is designed to automate standard immunohematology assays using a microplate based platform. Assays include ABO grouping and Rh (D) typing, detection / identification of IgG red blood cell antibodies, compatibility testing, red blood cell phenotyping, antigen screening and infectious disease screening, such as cytomegalovirus (CMV).